The compartment syndrome monitoring devices market is speculated to exhibit considerable expansion by 2027 owing to notable technological advancements in the treatment of compartment syndrome and IAH (intra-abdominal hypertension).

Compartment syndrome is a painful medical condition that is commonly caused due to trauma, sports injuries, and other chronic diseases, which increases the pressure within the muscles. This can reduce blood flow, depriving muscle cells and nerves of food and oxygen. Increasing occurrences of IAH and compartment syndrome have augmented industry uptake in recent years.

Notably, industry players have been employing lucrative strategies to gain a competitive edge in the evolving marketplace, thereby enhancing overall business outlook. For instance, in October 2021, MY01, Inc., a leading medical device company, received the Breakthrough Device Designation from FDA for its novel MY01 Continuous Compartmental Pressure Monitor. The continuous compartmental pressure monitor has been designed to give real-time and accurate pressure measurements for effective diagnosis of compartment syndrome.

The compartment syndrome monitoring devices market has been segmented on the basis of end-use, product, syndrome type, and region. In terms of product, the market has further been divided into equipment and disposables. The disposables sub-segment accounted for a notable share in the market with a valuation of around USD 42 million in 2020 and is slated to expand at a steady pace over 2021-2027. Recent advancements in devices are likely to drive product adoption over the study timeline.

With respect to syndrome type, the compartment syndrome monitoring devices market has been classified into abdominal compartment syndrome, acute compartment syndrome, and chronic compartment syndrome. In 2020, the abdominal compartment syndrome sub-segment was valued at more than USD 57.3 million and is projected to witness optimistic growth through 2027. Rising prevalence of abdominal compartment syndrome and IAH is set to fuel segmental development in the coming time period.

From the end-use perspective, the market has been bifurcated into clinics, hospitals, and others. The compartment syndrome monitoring devices industry share from the hospitals sub-segment is anticipated to reach a valuation of nearly USD 128 million by 2027. Mounting incidences of compartment syndrome among high-risk patients seeking treatment at emergency and intensive care units in hospitals are estimated to foster segmental expansion over the review timespan.

On the regional front, the Latin America compartment syndrome monitoring devices market attained a valuation of around USD 10 million in 2020 and is expected to showcase a solid growth trajectory over the forecast timeline. High prevalence of compartment syndrome and IAH in the LATAM region is likely to drive regional market growth over the forthcoming years.